W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Jinshi Biotechnology (Changsu) Co., Ltd. (doing business as Kingstronbio) is a Chinese company located in Changsu specializing in surgical and medical instruments and apparatus. It was founded in 2012 by Sheng Ping Zhong, he has been the CEO since that date.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France.

KOKA Lifesciences Co., Ltd. is a company headquartered in Shanghai, China, that manufactures and sells medical devices. The firm was founded in 2018. Ming Ming Wu is currently the CEO of the company.

Shandong Sidel Agricultural Equipment Co., Ltd., established on 2015-08-05, Business scope includes agricultural equipment research and development,manufacture,Sales;Goods and technology import and export business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Traverse Partners LLC, part of Hovnanian Enterprises, Inc., is a company headquartered in Mooresville, NC, that provides investment advice. It was founded by Jeff Janer.

Shanghai Weigao Medical Technology Development Co., Ltd., established on 2019-06-12, Business scope includes general items:working in medical technology,Medical Technology,Technology development in the field of detection technology,technical consulting,Technical Services,technology transfer,Medical device research and development,Engineering and Technology Research and Experimental Development,Business incubator management,software development,Sales,Enterprise Management Services,Business Consulting,marketing planning,Business Management Consulting,Import and export,Technology Import and Export,Manufacturing of plastic products,Sales,Manufacturing of rubber products,Sales,Manufacture of wire rope and its products,Sales,Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tendyne Holdings, Inc. is a clinical stage medical device company focused on the development of minimally invasive therapies for the treatment of mitral regurgitation. Mitral regurgitation is a condition that afflicts hundreds of thousands of individuals worldwide every year. Formed in 2010, their first product concept is a transcatheter mitral valve replacement prosthesis for the treatment of mitral regurgitation. The intent is for the valve to be deployed and secured with no disruption to the native mitral annulus while preserving the sub-valvular apparatus. Placement of the valve is intended to be completed transapically in a simple procedure where the implanting physician is able to re-position, remove, and re-deploy their valve throughout the procedure.

St. Jude Medical is a manufacturer of medical devices. Their product portfolio includes implantable cardioverter defibrillators, cardiac resynchronization therapy devices, pacemakers, remote monitoring systems, cardiac mapping and visualization systems, catheter-based ablation devices, vascular closure devices, structural heart products, spinal cord stimulation, peripheral nerve stimulation, and deep brain stimulation devices.

Shanghai Yixin Medical Equipment Co., Ltd., established on 2017-08-22, Business scope includes general items:Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices;Import and export;Technology Import and Export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Cardiovalve is a medical device company developing a transfemoral mitral valve replacement system. The flagship Cardiovalve system is the first one designed to replace the mitral valve using a transfemoral system. It is designed from the bottom up for transfemoral/transseptal delivery with femoral venous access. Cardivalve approach offers significant benefits, including a short profile for minimal protrusion to the left ventricle, minimizing interference in the cardiac blood flow and increased safety. It is currently evaluating the safety and performance of its system in clinical studies and it will seek EU and US approval.